Hinge Health, Inc. SEC Filings

HNGE insider Kristina Leslie has filed a Form 144 notice covering the proposed sale of 1,250 shares of HNGE common stock through Morgan Stanley Smith Barney LLC on the NYSE. The shares are valued at an aggregate market value of $57,106.00 based on the filing and are part of a class with 37,919,155 shares outstanding.

The filing shows these shares were acquired as restricted stock from the issuer, with 688 shares acquired on 04/01/2025 and 562 shares on 01/01/2025. Over the prior three months, Leslie reported additional open-market sales of HNGE common stock, including 3,813 shares sold on 11/19/2025 for gross proceeds of $166,257.86 and 2,187 shares sold on 11/18/2025 for $88,476.40.

HNGE filed a notice that an affiliated holder plans to sell common stock under Rule 144. The filing covers 15,000 shares of common stock with an aggregate market value of $680,400.00, to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE. The filing notes that there were 37,919,155 shares or other units outstanding at the time of the notice.

The shares to be sold were acquired as performance stock units from the issuer on 04/01/2023, with 15,000 securities acquired on that date and the payment nature listed as "N/A." The seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.

Hinge Health, Inc. (HNGE) reported an insider stock sale by its Chief Financial Officer. On 11/20/2025, the CFO sold 781 shares of Class A common stock at a price of $44.78 per share in an open-market transaction coded as a sale. This transaction was made under a pre-arranged Rule 10b5-1 trading plan adopted on June 12, 2025, which is designed to help insiders systematically sell shares over time. Following this sale, the CFO beneficially owns 524,467 shares of Hinge Health common stock in direct ownership.

Hinge Health, Inc. insider Bessemer entities reported major share moves. On November 18, 2025, Bessemer Venture Partners X L.P. and Bessemer Venture Partners X Institutional L.P. converted a total of 4,108,707 shares of Class B Common Stock into 4,108,707 shares of Class A Common Stock under terms described in the company’s charter. On the same date, they sold 725,000 shares of Class A Common Stock at a price of $40.05 per share.

After these transactions, the Bessemer funds reported indirect beneficial ownership of 3,383,707 shares of Class A Common Stock, consisting of 1,745,316 shares held by BVP X and 1,638,391 shares held by BVP X Inst. The reporting entities are described as director-level affiliates and 10% owners of Hinge Health, reflecting significant ongoing ownership even after the sale.

Hinge Health, Inc. (HNGE)November 18, 2025, Bessemer Venture Partners X L.P. converted 2,119,271 shares of Class B Common Stock into 2,119,271 shares of Class A Common Stock, and Bessemer Venture Partners X Institutional L.P. converted 1,989,436 Class B shares into 1,989,436 Class A shares.

On the same date, BVP X sold 373,955 shares of Hinge Health Class A Common Stock and BVP X Institutional sold 351,045 Class A shares. The reporting person, a partner at Bessemer Venture Partners, notes only an indirect, passive economic interest in these Bessemer funds and expressly disclaims beneficial ownership beyond any pecuniary interest.

HNGE filed a Form 144 notice for the proposed public sale of 45,370 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of $2,000,817.00 for these shares and states that 37,919,155 shares of the same class are outstanding. The seller acquired 781 shares on 11/15/2025 under an employee stock purchase plan and 44,589 shares on 06/01/2025 from restricted stock units, both from the issuer. By signing, the selling holder represents they are not aware of undisclosed material adverse information about HNGE.